Home / Featured Companies / Eli Lilly and Company Historical Data

Eli Lilly and Company (LLY) Financials

Eli Lilly and Company (LLY) Historical Financial Statements and Key Metrics for 1994 - 2023

Full Eli Lilly and Company financials for 1994 - 2023 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Eli Lilly and Company Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2023-Jun-30 8,312 6,505 (78.3 %) 2,126 (25.6 %) 1,763 (21.2 %) 2,320 1.95
2023-Mar-31 6,960 5,333 (76.6 %) 1,494 (21.5 %) 1,345 (19.3 %) 1,704 1.49
2022-Dec-31 7,302 5,754 (78.8 %) 1,836 (25.1 %) 1,938 (26.5 %) 2,555 2.04
2022-Sep-30 0 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 0 0.00
2022-Jun-30 6,488 5,058 (78.0 %) 1,650 (25.4 %) 952 (14.7 %) 1,521 1.05
2022-Mar-31 7,810 5,738 (73.5 %) 2,404 (30.8 %) 1,903 (24.4 %) 1,976 2.00
2021-Dec-31 8,000 5,950 (74.4 %) 1,917 (24.0 %) 1,726 (21.6 %) 2,367 1.81
Full historical income statements for 1994 - 2023 is included in the US Historical Financials dataset.

Eli Lilly and Company Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2023-Jun-30 54,814 43,665 18,820 11,064 2,829
2023-Mar-31 53,163 41,868 18,884 11,190 3,669
2022-Dec-31 49,490 38,714 16,239 10,650 2,212
2022-Sep-30 47,462 37,296 15,888 10,070 2,742
2022-Jun-30 47,064 38,404 16,814 8,545 2,737
2022-Mar-31 46,919 37,588 16,509 9,331 2,568
2021-Dec-31 48,806 39,651 16,885 8,979 3,909
Full historical balance sheet data for 1994 - 2023 is included in the US Historical Financials dataset.

Eli Lilly and Company Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2023-Jun-30 632 -459 -1,033 -204
2023-Mar-31 1,731 -689 412 827
2022-Dec-31 1,580 -860 -1,141 1,024
2022-Sep-30 2,185 -923 -1,263 1,565
2022-Jun-30 821 -464 -124 370
2022-Mar-31 2,499 -1,014 -2,878 2,134
2021-Dec-31 2,156 -379 -1,526 1,762
Full historical cash flow data for 1994 - 2023 is included in the US Historical Financials dataset.

Eli Lilly and Company Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2023-Jun-30 421,941 438,067 50.76 59.83 38.14
2023-Mar-31 310,205 325,543 44.57 57.66 27.72
2022-Dec-31 347,615 361,786 47.61 44.85 32.64
2022-Sep-30 0 0 0.00 0.00 0.00
2022-Jun-30 291,904 306,095 44.99 76.62 34.16
2022-Mar-31 273,098 287,147 34.97 35.88 29.27
2021-Dec-31 263,418 276,484 32.93 38.15 29.34
Full historical valuation and operating metrics for 1994 - 2023 are included in the US Historical Financials dataset.